Literature DB >> 26857878

The effects of pre-operative menopausal status and hormone replacement therapy (HRT) on sexuality and quality of life after risk-reducing salpingo-oophorectomy.

Paige E Tucker1, Max K Bulsara2, Stuart G Salfinger3, Jason Jit-Sun Tan4, Helena Green5, Paul A Cohen6.   

Abstract

OBJECTIVES: Investigate the effects of pre-operative menopausal status and HRT use on sexual outcomes following risk-reducing salpingo-oophorectomy (RRSO). STUDY
DESIGN: Cross-sectional study of 119 women who underwent RRSO between 2009 and 2014. MAIN OUTCOME MEASURES: Data was collected via a questionnaire and serum test for testosterone and free androgen index (FAI). The questionnaire comprised demographic data and validated measures of sexual function, sexual distress, relationship satisfaction, body image, psychological stress, menopause quality of life and general quality of life.
RESULTS: Rates of sexual issues were similar despite menopause status at operation. Women who were pre-menopausal at operation (mean age=44 years ± 5) had significantly higher rates of sexual distress (p=0.020), dissatisfaction with sex life (p=0.011) and bothersome sexual menopause symptoms (p=0.04) than women who were post-menopausal (mean age=55 years ± 7). Pre-menopausal women reported higher psychological distress from surgery (p=0.005) and poorer emotional (p=0.052) wellbeing. HRT use reduced the rates of dyspareunia (p=0.027) and the severity of sexual menopausal symptoms (p=0.030). Androgen levels were not significantly associated with desire or arousal scores.
CONCLUSIONS: Regardless of menopausal status at operation, women experienced the same sexual issues at equivalent rates. However, pre-menopausal women reported higher sexual distress and dissatisfaction with sex life. Pre-menopausal women also had greater psychological distress and poorer emotional function.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  BRCA1/2; Female sexual dysfunction; Hormone replacement therapy; Menopause; Risk-reducing salpingo-oophorectomy; Serum androgen levels

Mesh:

Substances:

Year:  2015        PMID: 26857878     DOI: 10.1016/j.maturitas.2015.12.004

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  7 in total

Review 1.  Hormone replacement therapy in young women with surgical primary ovarian insufficiency.

Authors:  Philip M Sarrel; Shannon D Sullivan; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2016-10-25       Impact factor: 7.329

2.  Cancer Anxiety Mediates the Association Between Satisfaction With Medical Communication and Psychological Quality of Life After Prophylactic Bilateral Salpingo-Oophorectomy.

Authors:  Cristina Zarbo; Agostino Brugnera; Luigi Frigerio; Chiara Celi; Angelo Compare; Valentina Dessì; Rosalba Giordano; Chiara Malandrino; Federica Paola Sina; Maria Grazia Strepparava; Isadora Vaglio Tessitore; Mariangela Ventura; Robert Fruscio
Journal:  Front Psychol       Date:  2022-03-09

3.  Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG study.

Authors:  Phuong L Mai; Helen Q Huang; Lari B Wenzel; Paul K Han; Richard P Moser; Gustavo C Rodriguez; John Boggess; Thomas J Rutherford; David E Cohn; Noah D Kauff; Kelly-Anne Phillips; Kelly Wilkinson; Robert M Wenham; Chad Hamilton; Matthew A Powell; Joan L Walker; Mark H Greene; Martee L Hensley
Journal:  Gynecol Oncol       Date:  2019-11-21       Impact factor: 5.482

Review 4.  The effect of hormone therapy on quality of life and breast cancer risk after risk-reducing salpingo-oophorectomy: a systematic review.

Authors:  Tasneem Siyam; Sue Ross; Sandra Campbell; Dean T Eurich; Nesé Yuksel
Journal:  BMC Womens Health       Date:  2017-03-21       Impact factor: 2.809

Review 5.  The fallopian tube as origin of ovarian cancer: Change of diagnostic and preventive strategies.

Authors:  Satoru Kyo; Noriyoshi Ishikawa; Kohei Nakamura; Kentaro Nakayama
Journal:  Cancer Med       Date:  2019-11-25       Impact factor: 4.452

6.  Hormone Levels and Sexual Functioning After Risk-Reducing Salpingo-Oophorectomy.

Authors:  Nora Johansen; Astrid H Liavaag; Lars Mørkrid; Trond M Michelsen
Journal:  Sex Med       Date:  2018-04-07       Impact factor: 2.491

7.  Does Type of Menopause Affect the Sex Lives of Women?

Authors:  Fatma Devran Bıldırcın; Emel Kurtoğlu Özdeş; Pervin Karlı; Ayşe Zehra Özdemir; Arif Kökçü
Journal:  Med Sci Monit       Date:  2020-01-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.